OrthoSpineNews

MARCH 3, 2025

This event marks the beginning of SST’s U.S.-based based trial to evaluate its PerQdisc system for patients suffering from degenerative disc disease (DDD). patient in its Investigational Device Exemption (IDE) clinical trial for the PerQdisc Nucleus Replacement Device (NRD).

Degenerative Disc Disease 52

Degenerative Disc Disease Patients Spine Clinic 52

OrthoSpineNews

MAY 13, 2025

No serious adverse events (SAEs) were reported, and there was no dose (40X10 6 cells) limiting toxicity at 26-104 weeks. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Clinic Treatment 52

ChiroTouch

JULY 19, 2024

Lightweight and easily transportable, portable tables are ideal for chiropractors who offer mobile services or need a flexible option for outreach events and home visits. These are standard tables used in many practices, providing a stable and reliable surface for various manual adjustments and treatments. Portable tables. Elevation tables.

X-ray 98

X-ray Soft Tissue Injuries Vertebrae Chiropractic 98

Any Spine

SEPTEMBER 30, 2024

Alleviating Chronic Back and Neck Pain Chiropractic spinal adjustments have proven effective in alleviating chronic back and neck pain, particularly for individuals with conditions such as degenerative disc disease.

Spinal Adjustment 52

Spinal Adjustment Adjustment Chiropractic Degenerative Disc Disease 52

OrthoSpineNews

JUNE 13, 2025

Excellent Safety Profile: No serious adverse events (SAEs) or dose-limiting toxicities reported between 26 and 104 weeks at the target dose (40 million cells). About the BRTX-100 Phase 2 Trial BRTX-100 is a novel, autologous cell-based therapy designed to treat patients suffering from painful lumbosacral disc degeneration.

Degenerative Disc Disease 64

Degenerative Disc Disease Lower Back Pain Clinic Treatment 64

OrthoSpineNews

MARCH 10, 2025

This minimally invasive technology aims to address unmet needs in treating lumbar spinal stenosis and degenerative disc disease, offering patients a less invasive alternative to traditional spinal surgery. CARLSBAD, Calif., We are incredibly proud to reach this milestone, said Trent Northcutt, President and CEO of Aurora Spine.

Degenerative Disc Disease 52

Degenerative Disc Disease Spine Clinic Musculoskeletal 52

OrthoSpineNews

MAY 14, 2025

Disc/Spine Program In a February podium presentation at the Orthopaedic Research Society (ORS) Annual Meeting, BioRestoratives Vice President of Research and Development, Francisco Silva, presented 2652 week blinded data from the first 15 patients with chronic lumbar disc disease (cLDD) enrolled in the ongoing Phase 2 clinical trial of BRTX-100.

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Neck Pain Treatment 52